Trujillo, Jennifer M.

GLP-1 receptor agonists: an updated review of head-to-head clinical studies

Trujillo, J. M., Nuffer, W., & Smith, B. A. (2021) · Therapeutic Advances in Endocrinology and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 289

GLP-1 receptor agonists: a review of head-to-head clinical studies

Trujillo, J. M., Nuffer, W., & Ellis, S. L. (2015) · Therapeutic Advances in Endocrinology and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 282

Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages

Whitley, H. P., Trujillo, J. M., & Neumiller, J. J. (2023) · Clinical Diabetes

Diabetes Treatment and ManagementPharmaceutical Economics and Policy

Cited by 132

Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline

Doyle-Delgado, K., Chamberlain, J. J., Shubrook, J. H., Skolnik, N., & Trujillo, J. (2020) · Annals of Internal Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 111

Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist

Tall Bull, S., Nuffer, W., & Trujillo, J. M. (2022) · Journal of Diabetes and its Complications

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 43

Impact of Sodium‐Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes

Trujillo, J. M., & Nuffer, W. A. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 42

Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness

Anderson, S. L., & Trujillo, J. M. (2016) · Therapeutic Advances in Chronic Disease

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 36